Laura Vidal Boixader

2.3k total citations
5 papers, 5 citations indexed

About

Laura Vidal Boixader is a scholar working on Economics and Econometrics, Molecular Biology and Genetics. According to data from OpenAlex, Laura Vidal Boixader has authored 5 papers receiving a total of 5 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Economics and Econometrics, 1 paper in Molecular Biology and 1 paper in Genetics. Recurrent topics in Laura Vidal Boixader's work include Radiomics and Machine Learning in Medical Imaging (1 paper), Ethics in Clinical Research (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Laura Vidal Boixader is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (1 paper), Ethics in Clinical Research (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). Laura Vidal Boixader collaborates with scholars based in Spain, United States and Israel. Laura Vidal Boixader's co-authors include María Jesús Rubio, Andrés Redondo, Nuria Romero-Laorden, Jesús García-Donás, Kelly K. Curtis, Pedro Gascón, Núria Laínez, Daniel Gandía, Merçè Brunet and José Antonio López‐Guerrero and has published in prestigious journals such as Journal of Clinical Oncology.

In The Last Decade

Laura Vidal Boixader

4 papers receiving 5 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Vidal Boixader Spain	2	2	2	1	1	1	5	5
Michael Castine United States	2	2 1.0×	2 1.0×				3	4
J Pereca United Kingdom	2	2 1.0×		1 1.0×			2	3
D. Andrew Tucker United States	2	2 1.0×					4	4
Samuel Finlay United Kingdom	2	2 1.0×					2	4
Merete Bechmann Christensen Denmark	2	2 1.0×					3	4
Iwona Kiecka United States	2	2 1.0×		1 1.0×			2	4
Hesler Morales Guatemala	2	2 1.0×			1 1.0×		2	2
Filip Jadrijević Cvrlje Croatia	2	2 1.0×			1 1.0×		2	2
Shristi Upadhyay United States	2	2 1.0×					3	3
Aritri Mandal United Kingdom	2	2 1.0×					2	4

Countries citing papers authored by Laura Vidal Boixader

Since Specialization

Citations

This map shows the geographic impact of Laura Vidal Boixader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Vidal Boixader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Vidal Boixader more than expected).

Fields of papers citing papers by Laura Vidal Boixader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Vidal Boixader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Vidal Boixader. The network helps show where Laura Vidal Boixader may publish in the future.

Co-authorship network of co-authors of Laura Vidal Boixader

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Vidal Boixader. A scholar is included among the top collaborators of Laura Vidal Boixader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Vidal Boixader. Laura Vidal Boixader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gandía, Daniel, et al.. (2024). Latin America and cancer clinical trials: Underrepresented region with significant growth potential.. Journal of Clinical Oncology. 42(16_suppl). e23038–e23038.

2.

Boixader, Laura Vidal, et al.. (2019). Reporting of patient reported outcome (PRO) in clinical trials: A systematic review of clinical trials.. Journal of Clinical Oncology. 37(15_suppl). 6590–6590. 1 indexed citations

3.

Boixader, Laura Vidal, et al.. (2017). Changes in numbers of randomized (RCT) versus non-randomized (NRCT) clinical trials from 2004-2016: Evidence of shifting cancer drug development pathway.. Journal of Clinical Oncology. 35(15_suppl). 2543–2543. 1 indexed citations

4.

Boixader, Laura Vidal, Lydia Gaba, Iván Victoria, et al.. (2015). Dose-escalation of the first-in human phase I/Ib study of ABTL0812, a novel antitumor drug inhibiting the Akt/mTOR pathway in patients with advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). 2585–2585. 1 indexed citations

5.

Garrigós, Laia, Alicia Hurtado, Ana Santaballa, et al.. (2014). Ketoconazole as inhibitor of the enzyme CYP17 in locally advanced or disseminated granulosa cell tumors of the ovary (the GreKo I study) (gethi 11-03).. Journal of Clinical Oncology. 32(15_suppl). 5558–5558. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact